Our global life sciences company brings diagnostic testing & drug development together.

Labcorp Insight Analytics: Beyond Data

Leverage Labcorp results data to help your organization manage patient care.

Labcorp believes that laboratory data can be a powerful tool in managing the health of your patients, as well as supporting your organization to meet Value-based Care requirements. We can provide a trusted source of national laboratory patient data and result values to help you identify high-risk patients and implement more effective clinical practices.

Welcome to Labcorp Insight Analytics.

Powerful insights at every level: population, provider, patient.

The interactive dashboards within Labcorp Insight Analytics go beyond data, and through web-based delivery options such as Labcorp Link, offer on-demand management and reporting tools that are intuitive to use.

To illustrate the breadth of insights that we can provide, you can view Insight Analytics Nationwide Snapshots:

Labcorp Report - Diabetes Prevalence (2019)

Diabetes remains a major public health concern, with estimates that it affects 30 million people in the U.S. and cost the overall health system at least $327 billion annually. Labcorp's Diabetes report utilizes commonly performed diabetes testing to document the prevalence of the disease throughout the U.S. population. The report uses only Labcorp testing data, and provides diabetes and prediabetes information at the state level for 2019.

Labcorp Report – Antibiotic Resistance in Bladder Infections (2019)

Urinary tract infections (UTI) caused by drug-resistant bacteria pose a serious threat to public health and can significantly increase healthcare costs.1 One major group of resistant bacteria includes members of the family Enterobacteriaceae (such as E. coli, Klebsiella species, and others) that produce extended-spectrum beta-lactamase (ESBL). ESBL provides resistance to multiple drugs, including penicillins, extended-spectrum cephalosporins, and monobactams.2 Using Labcorp data from antibiotic susceptibility testing, this snapshot shows the relative prevalence of community acquired UTIs caused by these ESBL-producing bacteria.